U.S. to force drug firms to report money paid to doctors
To head off medical conflicts of interest, the Obama administration is poised to require drug companies to disclose the payments they make to doctors for research, consulting, speaking, travel and entertainment. Many researchers have found evidence that such payments can influence doctors' treatment decisions and contribute to higher costs by encouraging the use of more expensive drugs and medical devices.
- Patient Harm Data to Remain on Medicare's Hospital Compare Site
- CMS Seeks to 'Rapidly Reduce' Medicare Spending with $1B in Grants
- Hard-Nosed About Physician Teamwork
- Quiet ORs Better for Patient Safety
- Building a Better Healthcare Board
- Case Study: Advance Care Conversations
- Tavenner Confirmed as CMS Administrator
- CMS Releases Hospital Pricing Data
- Leapfrog Hospital Safety Scores 'Depressing'
- Access to EHR Notes Lauded by Patients, Providers